tm
Seeing Is Believing
tm
Seeing Is Believing
VERV is currently covered by 8 analysts with an average price target of $23.24. This is a potential upside of $12.11 (108.81%) from yesterday's end of day stock price of $11.13.
Verve Therapeutics's activity chart (see below) currently has 42 price targets and 45 ratings on display. The stock rating distribution of VERV is 61.54% BUY and 38.46% HOLD.
Analysts average stock forecasts to be materialized ratio is 8.33% with an average time for these price targets to be met of 13.7 days.
Highest price target for VERV is $24, Lowest price target is $13, average price target is $15.83.
Most recent stock forecast was given by KOSTAS BILIOURIS from BMO on 27-Jun-2025. First documented stock forecast 12-Jul-2021.
Currently out of the existing stock ratings of VERV, 8 are a BUY (61.54%), 5 are a HOLD (38.46%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$13.5
$2.37 (21.29%)
$20
5 months 6 days ago
(27-Jun-2025)
0/4 (0%)
$2.2 (19.47%)
Hold
$13.5
$2.37 (21.29%)
$15
5 months 15 days ago
(18-Jun-2025)
0/7 (0%)
$2.38 (21.40%)
Hold
$13
$1.87 (16.80%)
5 months 16 days ago
(17-Jun-2025)
0/6 (0%)
$1.62 (14.24%)
Buy
$24
$12.87 (115.63%)
$64
7 months 18 days ago
(15-Apr-2025)
0/3 (0%)
$19.03 (382.90%)
Buy
$22
7 months 18 days ago
(15-Apr-2025)
1/3 (33.33%)
$9 (69.23%)
8
What is VERV (Verve Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on VERV (Verve Therapeutics) with a proven track record?
Which analyst has the most public recommendations on VERV (Verve Therapeutics)?
Which analyst is the currently most bullish on VERV (Verve Therapeutics)?
Which analyst is the currently most reserved on VERV (Verve Therapeutics)?
